Literature DB >> 2428856

Prostaglandin D2 and histamine release in cold urticaria.

D J Heavey, A Kobza-Black, S E Barrow, C G Chappell, M W Greaves, C T Dollery.   

Abstract

Prostaglandin (PG) D2 and histamine concentrations have been measured in blood draining cold-challenged forearm skin in patients with cold urticaria. Local venous concentrations of both histamine and PGD2 rose in four patients who developed a whealing response. Plasma histamine concentration increased from a mean resting value of 0.24 +/- 0.09 (SD) ng/ml to peak values of 16.9 to 96.6 ng/ml. Resting concentrations of PGD2 were below the limit of detection (5 pg/ml) in three patients and 62 and 27 pg/ml in the fourth. Peak plasma PGD2 concentration after challenge ranged from 166 to 279 pg/ml. Time course of histamine and PGD2 release was similar with peak concentrations at 6 and 10 minutes, respectively. The maximum clinical response occurred between 10 and 20 minutes after challenge. Our findings demonstrate that PGD2 is produced in association with mast cell degranulation in man, but the amount, relative to histamine, is low. Despite its high potency in production of inflammatory effects, PGD2 probably has only minor direct effects in cold urticaria, although it may act to potentiate other mediators.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428856     DOI: 10.1016/0091-6749(86)90033-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects.

Authors:  I Pollock; R D Murdoch; M H Lessof
Journal:  Agents Actions       Date:  1991-03

2.  Prostaglandin D2 release from human skin mast cells in response to ionophore A23187.

Authors:  R C Benyon; C Robinson; S T Holgate; M K Church
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.

Authors:  A I Mallet; P Norris; N B Rendell; E Wong; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 4.  Mast cells, neuropeptides and inflammation.

Authors:  M K Church; M A Lowman; P H Rees; R C Benyon
Journal:  Agents Actions       Date:  1989-04

5.  The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions.

Authors:  R M Barr; O Koro; D M Francis; A K Black; T Numata; M W Greaves
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

6.  Examination of the role of TRPM8 in human mast cell activation and its relevance to the etiology of cold-induced urticaria.

Authors:  Nevenka Medic; Avanti Desai; Hirsh Komarow; Lauranell H Burch; Geethani Bandara; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Cell Calcium       Date:  2011-09-08       Impact factor: 6.817

Review 7.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

8.  Etiological approach to chronic urticaria.

Authors:  D S Krupa Shankar; Mukesh Ramnane; Eliz Aryal Rajouria
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

9.  Alpha-fluoromethylhistidine in the treatment of idiopathic cold urticaria.

Authors:  H Neittaanmäki; J E Fräki; R J Harvima; L Förström
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  Evidence for histamine release in chronic inducible urticaria - A systematic review.

Authors:  Kanokvalai Kulthanan; Martin K Church; Eva Maria Grekowitz; Tomasz Hawro; Lea Alice Kiefer; Kanyalak Munprom; Yanisorn Nanchaipruek; Chuda Rujitharanawong; Dorothea Terhorst-Molawi; Marcus Maurer
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.